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HIV-affected couples have unique challenges that require access to information and reproductive
services which prevent HIV transmission to the uninfected partner and offspring while allowing
couples to fulfill their reproductive goals. In high HIV prevalent regions of sub-Saharan Africa,
HIV-affected couples require multipurpose prevention technologies (MPTs) to enhance their
reproductive healthcare options beyond contraception and prevention of HIV/sexually transmitted
infections (STIs) to include assistance in childbearing. The unique characteristics of the condom
and its accepted use in conjunction with safer conception interventions allow HIV-serodiscordant
couples an opportunity to maintain reproductive health, prevent HIV/STI transmission, and

Corresponding Author Okeoma Mmeje, MD, MPH, Assistant Professor, Reproductive Infectious Disease, Department of Obstetrics
and Gynecology, University of Michigan, L4100 Women’s Hospital, 1500 East Medical Center Drive, Ann Arbor, Michigan 48105,
ommeje@umich.edu, Phone: (734) 972-4843, Office: (734) 763-3429.
Craig R. Cohen MD, MPH, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco,
50 Beale Street, Suite 1200, San Francisco, CA 94105, ccohen@globalhealth.ucsf.edu
Alfred Murage MBChB, MRCOG, Department of Obstetrics and Gynaecology, Aga Khan University Hospital, Nairobi, P.O. Box
30270-00100, Nairobi, Kenya, alfred.murage@aku.edu
John Ong’ech MBChB, MMed, MPH, Kenyatta National Hospital, Doctors Plaza Suite 39, P.O. Box 26617-00504, Nairobi, Kenya,
jongech@pedaids.org
James Kiarie MBChB, MMed, MPH, Department of Obstetrics and Gynaecology, University of Nairobi, P.O. Box 3085-00506,
jkiarie@swiftkenya.com
Sheryl van der Poel MD, PhD, Physician Scientist, Department of Reproductive Health and Research, World Health Organization, 20,
Avenue Appia, CH-1211 Geneva 27, vanderpoels@who.int
Contribution to authorship
The manuscript was conceptualized by OM and SVP while OM was an intern at the WHO. CRC, AM, JO, and JK all contributed to
the development, writing and review of the manuscript with contributions drawn from their research and clinical experiences with
HIV-affected couples. OM and SVP led the writing process.
Disclosure of interests
The authors have no competing interests.

Mmeje et al.

Page 2

NIH-PA Author Manuscript

achieve their reproductive goals while timing conception. Rethinking the traditional view of the
condom and incorporating a broader reproductive health perspective of HIV-affected couples into
MPT methodologies will impact demand, acceptability, and uptake of these future technologies.

Keywords
HIV-serodiscordant couples; safer conception; HIV prevention; assisted reproductive services;
multipurpose prevention technology

Introduction
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HIV-serodiscordant couples, “a married or cohabiting couple in which one partner is HIVinfected and the other is HIV-uninfected,” are an important source of new HIV infections in
sub-Saharan Africa (SSA)1,2 where it is estimated that 23.5 million people are HIVinfected.3 For example, in Kenya, the national prevalence of HIV infection is estimated at
5.6% with an estimated 260,000 HIV-serodiscordant couples.4 HIV-infected individuals
have reproductive desires that cannot be ignored and they knowingly risk HIV transmission
in order to conceive.5-7 In HIV-serodiscordant partnerships in which pregnancy occurs, the
risk of HIV acquisition nearly doubles for the uninfected partner compared to partnerships in
which pregnancy does not occur.5 Furthermore, providing fertile HIV-infected women the
possibility of preserving their fertility and a safer option for conception is empowering given
the stigma and isolation they may already encounter as a result of their HIV status,
particularly in cultures where reproduction defines ones value in society.8-10 The
reproductive desires and intentions of HIV-infected individuals have not been adequately
addressed, particularly in low-resource environments,11 in relation to decreasing the risk of
unintended pregnancy and transmission of HIV, other sexually transmitted infections (STIs),
and resultant infertility. Infertility is a global public health problem with great implications
in SSA, specifically in HIV-affected couples (Figure 1). Therefore, the reproductive
intentions and prolonged periods of unprotected intercourse to achieve pregnancy among
HIV-infected individuals may reduce the impact of HIV prevention efforts unless
comprehensive reproductive services includingas multipurpose technologies (MPTs) equally
address contraception, childbearing desires and prevention of HIV/STIs.12, 13 Redefining
our view of the condom as a model MPT with integration of comprehensive HIV and
reproductive care counseling and education with provision of safer conception strategies will
successfully achieve the goal of prevention.
At the International Conference on Population Development in 1994, the accepted definition
of reproductive health, implied that women and men have the right to be “informed [about]

and have access to safe, effective, affordable and acceptable methods of family planning…
and appropriate healthcare services that will enable women to go through pregnancy and
childbirth and provide couples with the best chance of having a healthy infant”.14 This
definition of reproductive health has shaped and defined the health strategies of various
governmental and non-governmental organizations including that of the World Health
Organization’s (WHO) Department of Reproductive Health and Research. The vision of the
WHO’s Reproductive Health and Research division, which was adopted by United Nations
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member states in 2004, is “the attainment by all people of the highest possible level of
sexual and reproductive health.” Their intent is to conduct and support research initiatives
and develop public health policies that strive for a world in which women and men “have
access to sexual and reproductive health information services.” This is premised on the
concept of reproductive rights and assurance of choice when meeting the needs of diverse
populations, particularly those that have been neglected and at-risk. The current reproductive
health paradigm addresses universal access in the following five areas: maternal and
newborn health, “family planning,” preventing unsafe abortion, management of reproductive
tract and sexually transmitted infections, including HIV, and promotion of sexual health.
Linking the WHO’s Sexual and Reproductive Health (SRH) and HIV prevention objectives
and programs will enhance development of MPTs for the empowerment of women through
the prevention of HIV/STIs and provision of reproductive options.

NIH-PA Author Manuscript
NIH-PA Author Manuscript

Despite the intention of public health policies that provide universal access to reproductive
healthcare services, the reproductive desire to have children by HIV-affected individuals and
couples have not been adequately addressed. Furthermore, access to safe assisted fertility
interventions have been neglected within the global reproductive health agenda and “family
planning” discussions for HIV-serodiscordant couples.15 Comprehensive reproductive
services for HIV-affected couples should not only provide contraceptive services but also
assisted fertility services for those desiring children. According to the WHO SRH
Guidelines for women living with HIV/AIDS men and/or women with HIV/AIDS “may be
more likely to have difficulty getting pregnant and to request assistance. These women
should be given full support for counseling and advised of their options, including adoption
and assisted reproduction, if available.”16 Both simple and complex assisted reproductive
techniques, for HIV-affected couples with underlying infertility or subfertility, can provide a
means for conception that prevents partner transmission. Prior to the use of fertility services,
healthcare providers should consider educating and counseling HIV-affected couples on
fertility awareness methods and performing a fertility evaluation in the couple to assess for
underlying infertility, which may help direct them to the appropriate reproductive services.
Simple fertility methods include timed vaginal insemination (TVI) and sperm washing (SW)
with intrauterine insemination (IUI); and where indicated and economically feasible more
complex interventions such as in-vitro fertilization (IVF) with or without intracytoplasmic
sperm injection (ICSI) as HIV prevention interventions. In HIV-serodiscordant couples, a
water-based lubricated male condom is a critical fertility care technology for safe collection
of semen that avoids sexual HIV transmission in conjunction with any of the above methods.
These reproductive interventions avoid extended exposure with unprotected intercourse in
couples desiring children.
All these methods require the consistent use of male condoms, or if found acceptable female
condoms, which would decrease the incidence of unintended pregnancy and HIV/STI
transmission. Most importantly, the range of reproductive methods offered with the
consistent use of condoms will allow HIV-infected men and women the option of choosing
the method best suited to their current situation and reproductive health priority, either for
contraception or safer conception. As a result of rebranding the condom there is new
motivation to increase their consistent use. Overall, options that address the full complement
of reproductive health needs will enhance uptake and acceptance of MPT methodologies.
BJOG. Author manuscript; available in PMC 2015 October 01.
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Pharmaceutical methods, such as the use of antiretroviral therapy in the HIV-infected
partner, have been demonstrated to decrease the risk of sexual HIV transmission.17, 18 In
addition, antiretroviral therapy may be administered to the uninfected partner in an HIVserodiscordant relationship during the periconception period as pre-exposure prophylaxis
(PrEP).19 A recent report from the United Kingdom has shown that timed unprotected
intercourse along with the use of PrEP by the HIV-uninfected female in the periovulatory
period demonstrated feasibility and decreased the risk of sexual and perinatal HIV
transmission.21 Thus, safer conception practices that utilize either a reproductive and/or
pharmaceutical intervention should be part of the arsenal of options offered to HIVserodiscordant couples, which will assist in decreasing the risk of sexual and perinatal HIV
transmission to uninfected partners and developing fetus. MPTs are being developed to
address a complimentary component to provide contraception, however they can be
innovatively modified to address the needs of safer conception.
Worldwide, the gap in access and provision of reproductive healthcare services for HIVinfected individuals affects their quality of life and social status.11 An expanded
reproductive health paradigm, which includes MPTs, is needed to enhance awareness,
options, and access to reproductive services for HIV-affected women and men.

NIH-PA Author Manuscript

MPTs and Safer Conception

NIH-PA Author Manuscript

The MPTs (i.e. antiretroviral, monoclonal antibodies, and contraceptive impregnated gels,
rings and barrier devices) in development are not readily available on the market for high
risk individuals or HIV-serodiscordant couples to use for prevention of HIV/STI or in
conjunction with safer conception interventions. None of the proposed products can be used
to prevent transmission/acquisition of STIs while allowing HIV-serodiscordant couples the
option of safely conceiving with safer conception interventions. The only product that may
provide HIV-serodiscordant couples the opportunity to fulfill their reproductive right of
childbearing when they desire and also prevent HIV transmission/acquisition is the condom
(male or female). Furthermore, the proposed and ongoing pre-clinical and clinical studies of
these products have yet to evaluate the impact of antiretroviral, monoclonal antibodies, and
contraceptive agents on the reproductive tract (i.e. impact on sperm, endometrial
environment for implantation, and embryo development). Despite some of the promising
evidence supporting the use of MPTs, their availability, accessibility and acceptability are
still in question. If high risk individuals and HIV-affected couples are presented with options
that meet their full reproductive and HIV/STI prevention needs, demand and acceptability
will likely increase. To ensure a successful platform, the MPT development strategies need
to address prevention, contraceptive and fertility needs of high risk individuals and HIVaffected couples.

The State of Affairs: Reproductive Guidelines for HIV-Affected Couples
At the beginning of the HIV epidemic in 1985 in the United States of America (USA), the
Centers for Disease Control and Prevention (CDC) discouraged HIV-infected women from
having children because of the poor prognosis associated with HIV infection and the risk of
perinatal transmission. Advances in HIV prevention and treatment have allowed HIV-

BJOG. Author manuscript; available in PMC 2015 October 01.

Mmeje et al.

Page 5

NIH-PA Author Manuscript

infected individuals to live longer and pursue their reproductive goals hence there are now
recommendations guiding individuals in this process.21 The American College of Obstetrics
and Gynecology (ACOG) recommends that in HIV-serodiscordant partnerships with an
HIV-infected man, “assisted conception with sperm washing for intrauterine insemination or

NIH-PA Author Manuscript

intracytoplasmic sperm injection may be safer than timed unprotected intercourse with
regard to HIV transmission.”22 Similarly, the American Society for Reproductive Medicine
(ASRM) recommends that “when an affected couple requests assistance to have their own
genetically related child, they are best advised to seek care at institutions with the facilities
that can provide the most effective evaluation treatment and follow-up.”23 Furthermore,
ASRM asserts that in couples with an HIV-infected man, the use of sperm preparation
techniques coupled with IUI or ICSI have been demonstrated to be highly effective in
preventing seroconversion of HIV-uninfected women and offspring.23 In HIVserodiscordant couples with an HIV-infected female, TVI in the periovulatory period is a
low cost intervention that couples can utilize to prevent sexual HIV transmission while
attempting conception. A collected semen sample obtained after either natural coitus with a
water-based lubricated condom or ejaculation into a clean cup is inseminated with a syringe
into the vagina during the periovulatory period. However, advanced assisted reproductive
techniques may still be indicated in the presence of underlying infertility.19, 24 - 26 The
position statements of these organizations are also in agreement with that of the European
Society of Human Reproduction and Embryology.27 In Spain, some clinicians endorse timed
unprotected intercourse in HIV-serodiscordant couples desiring children when the following
conditions are met: an undetectable serum HIV-RNA, antiretroviral therapy in the infected
partner, absence of genital tract infections, and a normal fertility evaluation in the
couple.28, 29 However, some argue that timed unprotected intercourse should not be
endorsed in high risk HIV-serodiscordant couples who wish to conceive. Unprotected sexual
intercourse in high risk situations when the above conditions cannot be assured is
discouraged; therefore, preconception counseling, SW-IUI or ICSI are ideal options when
the male partner is HIV-infected.30, 31 Most recently, there have been clinical and laboratory
innovations resulting in lower cost IVF interventions, which may be adapted for lowresource environments.32

Reproductive Services in High-Resource Countries
NIH-PA Author Manuscript

The use of assisted reproductive services such as SW-IUI or IVF should not only be
considered as methods of enhancing fertility or addressing underlying infertility but as
critical components of the HIV prevention armamentarium coupled with consistent condom
use.33 In the USA, there have been no reported cases of HIV transmission to the HIVuninfected female partner with the use of SW and ICSI.33, 34Similarly, there have been no
reported cases of HIV transmission with the use of SW-IUI worldwide.34 - 36 In highresource countries (World Bank classifications), assisted reproductive services for HIVaffected couples are available and have been determined to be effective and safe in
retrospective studies.37 However, these services are not accessible and/or affordable to the
majority of couples in need, specifically in the public healthcare arena in low-resource
settings.38 HIV-serodiscordant couples receiving assisted reproductive services in Italy,
believed that it was “not right to withhold something as important to procreation [from]
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people because they have a disease”8 because it provided a safer alternative to natural
conception, although not risk free. Overall, couples living with HIV believe that society has
a moral obligation to help them find solutions that will assist in overcoming their barriers to
access and providing choice through information on safer conception alternatives to natural
conception.8

NIH-PA Author Manuscript

In the USA, less than three percent of assisted reproductive practices registered with ASRM
provide services to couples in whom one or both partners are HIV-infected.23 The limited
access and barriers to services has been attributed to concerns about transmission to clinical
personnel and contamination of gametes and embryos stored on clinical premises; however,
there have been no reported cases of occupational HIV transmission to personnel, gametes
or embryos in the clinical setting that would support limiting services to HIV-affected
couples.23 The current costs of this level of assisted reproductive services has made it an
unattainable service for a significant proportion of HIV-affected couples – in high, low and
middle income countries. Current estimates in high income countries can range from
$10,000 - $17,000 per cycle of advanced assisted reproductive services and can be as high as
$25,000.39 In low and middle income countries, the International Federation for Fertility
Services (IFFS) has found that the average cost is from $3,000 - $8,000 per cycle, which is
proportionately more expensive based upon GDP values in these countries.40

NIH-PA Author Manuscript

Despite evidence supporting a decreased risk of HIV transmission in serodiscordant
partnerships with the use of safer conception techniques, there are few prospective studies
evaluating the acceptability and feasibility of these methods amongst HIV-serodiscordant
couples who desire children, especially in SSA. Although SW-IUI represents one of the
lower cost options, the CDC has not changed its recommendation since 1990 against SWIUI. The CDC’s position is based on a single reported case of HIV seroconversion in a
woman using improper techniques.41, 42 As a result, the use of approved assisted
reproductive technology for male HIV-infected serodiscordant couples has been limited to
SW-ICSI in the USA, which has also limited the availability of these services due to high
costs and restricted access particularly in public health settings. The National Perinatal HIV
Hotline and Clinicians Network (“The Perinatal HIV Hotline”) as of March 2013 reported
only 17 clinics offering IVF and seven offering SW-IUI to HIV-serodiscordant couples.43
The number of service providers may be limited as a result of the existing CDC
recommendations. As of 2003, the CDC outlined three components that must be fulfilled
before it would change its policy statement and consider the endorsement of insemination
for HIV-affected couples: expansion of the follow-up of European women inseminated with
processed semen, evaluation of the effectiveness of laboratory techniques for removing HIV
from semen, and evaluation of the transfer of technology of semen processing to nonresearch settings.42 We believe that the evidence required to support new policy guidelines
endorsing the use of SW-IUI by the CDC as a safer method of conception for HIV-affected
couples already exists; however, the decision has not been overturned. Global leaders who
shape public policy agendas should reconsider the scientific evidence that could enhance the
provision of safer conception options as MPTs to HIV-affected couples desiring children.
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The pronatalist nature of many low-resource countries defines individuals through
parenthood and children are highly valued by cultural norms.44, 45 In SSA, many HIVinfected women and men express a desire for children either immediately or in the near
future and being without a child attracts significant stigma.11 HIV-infected women report
that pregnancy and childbirth are ways for them to regain their sense of womanhood and
sexuality, often making childbearing a high personal priority.46 To these women, “family
planning” is not just prevention and management of unwanted pregnancy but also planning
for their family with the assistance of their healthcare provider and the provision of clinical
services.45 Therefore, in cultures where self-worth and identity are inextricably linked to
childbearing, encouraging HIV-affected couples to abstain from reproduction or to
consistently use condoms while not providing any support and information on options to
safely conceive are unrealistic. Therefore, the incorporation of safer conception strategies
with condoms as an MPT is critical to addressing reproductive desires, HIV/STI prevention,
and contraception depending on the circumstances and reproductive desires of the HIVinfected individual.

NIH-PA Author Manuscript
NIH-PA Author Manuscript

In low resource-environments, the cost, availability, and knowledge of assisted reproductive
services may limit their accessibility to HIV-affected couples.38 To date, three assisted
reproductive clinics in Nairobi, Kenya provide safer conception interventions for HIVaffected couples desiring children (Personal communication – Dr. Alfred Murage). Although
timed unprotected intercourse is theoretically an acceptable intervention because it can be
easily adapted and accepted by healthcare providers and HIV-affected couples in lowresource environments, there are inherent challenges to its use and reliability as the only
safer conception option for HIV-affected couples. It may be unethical to recommend timed
unprotected intercourse as a means of safer conception for high risk HIV-serodiscordant
couples despite the lack of costs associated with this method in low-resource environments
where adherence to antiretroviral therapy and HIV RNA viral load assessments are not
readily available. Furthermore, in HIV-serodisordant couples in SSA with underlying
infertility (Figure 1), conception may not occur thus unprotected sexual encounters aimed at
achieving conception may be futile with continued risk of HIV transmission. Other safer
conception interventions require evaluation to expand the repertoire of services and options
available to HIV-affected couples desiring children. Redefining reproductive health
strategies to include access to fertility services and innovative uses for MPT beyond
contraception has the potential to improve the nature and quality of reproductive services for
women and men worldwide.

Expansion of the Reproductive Health Paradigm for HIV-Affected Couples
Closing the reproductive services gap will require an acknowledgement and support of the
reproductive intentions and fertility desires of HIV-affected couples.47 Therefore, public
health agencies, ministries of health, policy makers, healthcare providers, researchers and
donors must first acknowledge the reproductive intentions as well as the associated
challenges of preventing HIV transmission in HIV-serodiscordant couples who desire a
biological family.13 Closing the gap in clinical services will require integration of
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reproductive healthcare services into HIV prevention interventions along with the
development of evidence-based clinical guidelines for healthcare providers. These
guidelines will expose the research and product gaps creating a need for MPTs that address
multiple reproductive health needs.

NIH-PA Author Manuscript

Implementation studies need to be conducted to ensure that the successful outcomes
reported in high-resource settings can be replicated in low-resource environments with a
high HIV prevalence. These studies should evaluate whether interventions such as consistent
condom use with TVI during the periovulatory period and SW-IUI are feasible and
acceptable to healthcare providers and HIV-affected couples as components of HIV
prevention interventions. The findings of these studies will help define the cadre of best
practices for reproductive fertility services and product demands that will meet the
satisfaction of healthcare providers and HIV-affected couples. Enhancing the understanding
of healthcare providers around HIV related stigma may require adoption of new skills that
will create an engaging environment for reproductive discussions and preconception
counseling with HIV-affected couples. These discussions will help facilitate the continuum
of care from preconception to the postpartum period once pregnancy is achieved.
Furthermore, reproductive healthcare training programs are needed in order to effectively
enhance the availability and quality of information provided to HIV-affected individuals.48
Pre-service training for nurses, clinical officers, medical officers, and community health
workers has been critical to the successful scale up of HIV prevention, care and treatment
services in low-resource environments.49 Expanding the perspective of healthcare providers
in training on “family planning” will have a great impact on changing the mindset of future
generations to come to improve the lives of those they serve. In low-resource environments,
public-private partnerships may help bring technical expertise, research and equipment,
which may improve the provision of affordable assisted reproductive services50 and
interventions that include innovative MPTs.

Conclusion
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An expanded reproductive health paradigm requires redefining the “family planning” vision
with the embracement of the fertility intentions of all women and men, including those with
HIV, who maintain a desire to have children. In an expanded reproductive health paradigm,
fertility evaluations and assisted reproductive services should not only be considered for the
infertile but also for those seeking safer conception and for HIV prevention. MPT product
development should focus on the multipurpose nature and characteristics inherent to the
condom. Like the condom, new MPTs should offer: short term or single use, prevention of
HIV/STIs and subsequent infertility, and unintended pregnancy. Providing fertile HIVinfected women with the possibility of preserving their fertility and a safer option for
conception is empowering given the stigma and isolation they may already encounter as a
result of their HIV status, particularly in cultures where reproduction defines one’s value in
society. Despite some of the promising evidence supporting the use of MPTs, their
availability, accessibility and acceptability are still in question. The prospect of an HIVuninfected partner and child may be a strong motivator for uptake of old and new MPTs in
the future.
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Webfigure 14:Exposure to secondary infertility (out of all women) in 1990 (top) and 2010
(bottom). In fertility exposure is indexed on the female partner, age-standarized prevalence
amount all women.
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